Chronic kidney disease after nonrenal solid-organ transplantation

被引:152
作者
Bloom, Roy D. [1 ]
Reese, Peter P. [1 ]
机构
[1] Univ Penn, Renal Elect & Hypertens Div, Dept Med, Philadelphia, PA 19104 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2007年 / 18卷 / 12期
关键词
D O I
10.1681/ASN.2007040394
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease (CKD) is a common complication after nonrenal solid-organ transplantation. The risk for CKD is influenced by many factors, some of which have a direct impact on how such patients are treated in the pre-, peri-, and posttransplantation settings. This review describes hazards for acute and chronic kidney injury, with particular emphasis on calcineurin inhibitor-mediated nephrotoxicity. Rather than a detailed description of management issues that are common to the general CKD population, highlighted are aspects that are more specific to nonrenal solid-organ transplant recipients with a focus on liver, heart, and lung recipients. Strategies to minimize nephrotoxic insults and retard progressive renal injury are discussed, as are issues that are pertinent to dialysis and transplantation. Finally, future approaches to prevent and treat CKD without compromising function of the transplanted organ are addressed.
引用
收藏
页码:3031 / 3041
页数:11
相关论文
共 104 条
  • [1] The outcome of heart transplant recipients following the development of end-stage renal disease: Analysis of the Canadian Organ Replacement Register (CORR)
    Alam, A.
    Badovinac, K.
    Ivis, F.
    Trpeski, L.
    Cantarovich, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (02) : 461 - 465
  • [2] Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy
    Artz, MA
    Hilbrands, LB
    Borm, G
    Assmann, KJM
    Wetzels, JFM
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (11) : 2852 - 2857
  • [3] Cyclosporine A up-regulates angiotensin II receptors and calcium responses in human vascular smooth muscle cells
    Avdonin, PV
    Cottet-Maire, F
    Afanasjeva, GV
    Loktionova, SA
    Lhote, P
    Ruegg, UT
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (06) : 2407 - 2414
  • [4] Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil
    Barkmann, A
    Nashan, B
    Schmidt, HHJ
    Böker, KHW
    Emmanouilidis, N
    Rosenau, J
    Bahr, MJ
    Hoffmann, MW
    Manns, MP
    Klempnauer, J
    Schlitt, HJ
    [J]. TRANSPLANTATION, 2000, 69 (09) : 1886 - 1890
  • [5] NATURE AND EXTENT OF GLOMERULAR INJURY INDUCED BY CYCLOSPORINE IN HEART-TRANSPLANT PATIENTS
    BERTANI, T
    FERRAZZI, P
    SCHIEPPATI, A
    RUGGENENTI, P
    GAMBA, A
    PARENZAN, L
    MECCA, G
    PERICO, N
    IMBERTI, O
    REMUZZI, A
    REMUZZI, G
    [J]. KIDNEY INTERNATIONAL, 1991, 40 (02) : 243 - 250
  • [6] Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A
    Binet, I
    Wallnöfer, A
    Weber, C
    Jones, R
    Thiel, G
    [J]. KIDNEY INTERNATIONAL, 2000, 57 (01) : 224 - 231
  • [7] Kidney disease after heart and lung transplantation
    Bloom, RD
    Doyle, AM
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (04) : 671 - 679
  • [8] Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus
    Bloom, RD
    Rao, V
    Weng, F
    Grossman, RA
    Cohen, D
    Mange, KC
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (05): : 1374 - 1380
  • [9] Measuring renal function in solid organ transplant recipients
    Borrows, Richard
    Cockwell, Paul
    [J]. TRANSPLANTATION, 2007, 83 (05) : 529 - 531
  • [10] Improvement of renal function in pediatric heart transplant recipients treated with low-dose calcineurin inhibitor and mycophenolate mofetil
    Boyer, O
    Le Bidois, P
    Dechaux, M
    Gubler, MC
    Niaudet, P
    [J]. TRANSPLANTATION, 2005, 79 (10) : 1405 - 1410